Parkinson's Disease

Parkinson's disease is a brain disorder. It occurs when certain nerve cells (neurons) in a part of the brain called the substantia nigra die or become impaired. When approximately 80 percent of neurons are damaged, the symptoms of Parkinson's disease appear. Parkinson's disease affects 1 in 100 people over the age of 60, with the average age of onset being 60 years. The risk of developing Parkinson's disease increases with age. In the United States, it is estimated that 60,000 new cases of Parkinson's disease are diagnosed each year, with 1.5 million Americans currently living with the disease.

Overview

Feature Articles

Latest Parkinson's Disease News and Research

Impact of orally administered cannabidiol (CBD) on fitness and health among healthy adult individuals

Impact of orally administered cannabidiol (CBD) on fitness and health among healthy adult individuals

Conventional speech therapy and singing may help improve patients' voice problems with Parkinson's

Conventional speech therapy and singing may help improve patients' voice problems with Parkinson's

People with focal epilepsy often have seizures while driving before a diagnosis

People with focal epilepsy often have seizures while driving before a diagnosis

People with insomnia symptoms may have higher stroke risk

People with insomnia symptoms may have higher stroke risk

Long Covid-related fatigue impacts daily lives of patients more than some cancers

Long Covid-related fatigue impacts daily lives of patients more than some cancers

Study identifies new altered neural circuits in Huntington’s disease

Study identifies new altered neural circuits in Huntington’s disease

Spinal neural circuit dysfunction mediates movement symptoms in dystonia

Spinal neural circuit dysfunction mediates movement symptoms in dystonia

Progesterone could be used in the fight against Parkinson’s disease

Progesterone could be used in the fight against Parkinson’s disease

Parkinson's disease drug ropinirole is safe and tolerable for ALS patients, early clinical trial shows

Parkinson's disease drug ropinirole is safe and tolerable for ALS patients, early clinical trial shows

Study explores the link between sleep apnea and brain volume

Study explores the link between sleep apnea and brain volume

Ultraflexible nanoelectrodes improve the efficacy of brain stimulation

Ultraflexible nanoelectrodes improve the efficacy of brain stimulation

Novel assay for identifying individuals with synucleinopathies using serum samples

Novel assay for identifying individuals with synucleinopathies using serum samples

Research could help develop better treatments for swallowing disorders

Research could help develop better treatments for swallowing disorders

People with Alzheimer's disease more likely to develop epilepsy and vice versa

People with Alzheimer's disease more likely to develop epilepsy and vice versa

New approach helps measure individual limb contributions to standing postural control

New approach helps measure individual limb contributions to standing postural control

Gut bacteria toxins: A hidden trigger for Parkinson's disease?

Gut bacteria toxins: A hidden trigger for Parkinson's disease?

Researchers identify brain signatures for chronic pain in a small group of individuals

Researchers identify brain signatures for chronic pain in a small group of individuals

Regular exercise may decrease the risk of developing Parkinson's disease

Regular exercise may decrease the risk of developing Parkinson's disease

New technique may reveal signs of Parkinson's disease in urine samples

New technique may reveal signs of Parkinson's disease in urine samples

Nemours Children's Health selected to conduct first gene therapy clinical trial for Morquio A syndrome

Nemours Children's Health selected to conduct first gene therapy clinical trial for Morquio A syndrome